Purdue Pharma LP and its billionaire owners won a temporary reprieve from nearly 2,700 opioid lawsuits, giving the bankrupt drugmaker time to clinch a deal that would atone for its role in America’s addiction epidemic. U.S. Bankruptcy Judge Robert D. …
A federal appeals court on Thursday cleared the way for a landmark trial over the nation’s opioid crisis, rejecting a bid by eight drug retailers and distributors to disqualify the judge, and a request by Ohio and other U.S. states …
The city of Vancouver has filed a lawsuit against major opioid producers and suppliers, joining a long list of cities seeking restitution for the drug’s impact on their communities. The Columbian reports the lawsuit filed this week in U.S. District …
The Cleveland judge overseeing more than 2,000 federal lawsuits over alleged opioid abuses refused to disqualify himself from a bellwether trial set to start next month, rejecting a request by drug distributors and pharmacies who say he is biased against …
AmerisourceBergen Corp., Cardinal Health Inc., CVS Health Corp. units and other prescription drug distributors and pharmacies moved to bounce Cleveland federal judge Dan Polster from the massive opioid liability case he’s overseeing, claiming he’s likely biased against them. The Saturday …
Purdue Pharma LP, maker of the highly addictive Oxycontin painkiller, is pitting state against state with its offer of about $12 billion to resolve the company’s liability for the massive public-health crisis tied to opioid abuse that’s swept the U.S. …
A U.S. judge on Tuesday rejected efforts by major drugmakers, pharmacies and distributors to dismiss claims that they caused the nation’s opioid crisis, clearing the way for a scheduled landmark trial even as he pushes for a nationwide settlement. U.S. …
OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday. Purdue …
While some Johnson & Johnson investors were relieved that the company’s $572 million penalty for fueling Oklahoma’s opioid epidemic wasn’t as high as feared, lawyers for other U.S. states, cities and counties could hardly contain their glee. That’s because the …
Newly released federal data shows how drugmakers and distributors increased shipments of opioid painkillers across the U.S. as the nation’s addiction crisis accelerated from 2006 to 2012. The data, released this week by a federal court in Ohio as part …
